|
Important Safety Information for Lantus®
Prescription Lantus® is for adults with type 2 diabetes or adults and children
(6 years and older) with type 1 diabetes who require long-acting insulin for the
control of high blood sugar.
OptiClik® is a reusable insulin delivery device for use with a
3-mL Lantus® cartridge (U-100). Needles, OptiClik® and cartridge systems must not
be shared.
DO NOT DILUTE OR MIX LANTUS® WITH ANY OTHER INSULIN OR SOLUTION. It will
not work as intended, and you may lose blood sugar control, which could be serious.
Do not change your insulin without talking with your doctor. The syringe
must not contain any other medication or residue. You should not use Lantus®
if you are allergic to insulin. Lantus® is a long-acting insulin you inject
just once a day, at the same time each day. You must test your blood sugar levels
while using an insulin such as Lantus®.
The most common side effect of insulin, including Lantus®, is hypoglycemia,
which may be serious. Other possible side effects may include injection
site reactions, including changes in fat tissue at the injection site, and allergic
reactions, including itching and rash. In rare cases, some allergic reactions may
be life threatening. Tell your doctor about other medicines and supplements you
are taking because they can change the way insulin works.
Click
here for Additional Important Information for Lantus®
Important Safety Information for Apidra®
Prescription Apidra® is for adults with type 2 diabetes or adults and children
(4 years and older) with type 1 diabetes to improve blood sugar control. Do not
use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are allergic
to any of the ingredients in Apidra®. Apidra® should normally be used with a
longer-acting insulin.
OptiClik® is a reusable insulin delivery device for use with a 3-mL Apidra®
cartridge (U-100). Needles, OptiClik® and cartridge systems must not be
shared.
Apidra® has a more rapid onset and shorter duration of action than regular human
insulin. When used as a mealtime insulin, Apidra® should be given within 15
minutes before or within 20 minutes after starting a meal. Do not change your dose
or the type of insulin you use without talking with your treating healthcare provider.
Tell your doctor about all of your medical conditions, as well as other medicines
and supplements you are taking. Check your blood sugar levels while
on insulin therapy, such as Apidra®.
The most common side effect of insulin therapy, including Apidra®, is low blood
sugar (hypoglycemia). Other possible side effects may include low blood potassium,
injection site reactions, such as changes in fat tissue at the injection site, and
allergic reactions, such as itching and rash. Less common, but potentially more
serious or life-threatening, is generalized allergy to insulin, including anaphylactic
reactions.
When used in a pump, do not mix Apidra® with any other insulin or liquid.
Click
here for Additional Important Information for Apidra®
|